Shire announces divestiture of Daytrana to Noven Pharmaceuticals
Links shared publicly online about this topic.
- 955total visits
Shire announces divestiture of Daytrana to Noven Pharmaceuticals
View full resource at news-medical.net
Tags: Stroke, ADHD Medication, Thrombotic Event, Pharma, Concerta, Metadate CD, Shire, News
Most Recently Shared on August 11, 2010 at 4:46 pm By:
Stroke News: Shire announces divestiture of Daytrana to Noven Pharmaceuticals: Shire plc, the global specialty b... http://twurl.nl/20p7k8
Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire - Drugs.com MedNews
drugs.com — “First and Only Patch for ADHD Now to be Marketed and Sold by Noven Therapeutics Oct 1, 2010 - Noven Pharmaceuticals, Inc. today announced that it has completed” View full resource at drugs.com
Most Recently Shared on October 1, 2010 at 4:19 pm By:
Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire: First and Only P... http://bit.ly/9YGHxH #drug
Noven acquires global rights to Daytrana from Shire affiliates
news-medical.net — “Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc.” View full resource at news-medical.net
Most Recently Shared on October 1, 2010 at 2:20 pm By:
Noven acquires global rights to Daytrana from Shire affiliates: Noven Pharmaceuticals, Inc. today announced that i... http://bit.ly/dpepvb
Shire To Divest Brain Stimulator Daytrana To Noven Pharma; Maintains FY10 Earnings View
rttnews.com — “Specialty biopharmaceutical company Shire plc, Tuesday announced the divestiture of its brain stimulant medicine Daytrana to Noven Pharmaceuticals, Inc., granting Noven global marketing rights for the medicine, effective October 1, 2010.” View full resource at rttnews.com
Most Recently Shared on August 11, 2010 at 3:09 am By:
Shire To Divest Brain Stimulator Daytrana To Noven Pharma; Maintains FY10 ... http://bit.ly/ahRdPa #ADHD
Advertisement

